Adenocarcinoma of the Lung
📧 Sign up to get email alerts when something new happens for Adenocarcinoma of the Lung.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-07-23Clinical Trial Update: NM32-2668 in Adult Patients With Selected Advanced Solid Tumors [Phase 1]
A Phase 1 trial of NM32-2668 in adults with selected advanced solid tumors has been terminated. The study enrolled multiple tumor types incl…
-
CLINICAL_TRIALS trial_result · 2024-05-09Clinical Trial Update: Rigosertib Plus Nivolumab for KRAS+ NSCLC Patients Who Progressed on First-Line Treatment [Phase 1, Phase 2]
Completed Phase 1/2 trial evaluating the combination of rigosertib and nivolumab in KRAS-positive non-small cell lung cancer patients who pr…
-
CLINICAL_TRIALS trial_result · 2024-02-06Clinical Trial Update: Feasibility and Safety of Nintedanib in Combination With Nivolumab in Pretreated Patients With Advanced or Metastatic NSCLC of Adenocarcinoma Histology [Phase 1, Phase 2]
Phase 1/2 trial evaluating the feasibility and safety of nintedanib in combination with nivolumab in pretreated advanced or metastatic adeno…
-
CLINICAL_TRIALS trial_result · 2022-06-16Clinical Trial Update: EUCROSS: European Trial on Crizotinib in ROS1 Translocated Lung Cancer [Phase 2]
Phase 2 trial update of crizotinib in ROS1-translocated lung cancer (EU CROSS) completed.
-
CLINICAL_TRIALS trial_result · 2022-02-11Clinical Trial Update: Study of Ponatinib in Patients With Lung Cancer Preselected Using Different Candidate Predictive Biomarkers [Phase 2]
Phase 2 trial evaluating ponatinib in lung cancer patients preselected by predictive biomarkers; study completed with results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-10-15Clinical Trial Update: ctDNA-MRD Based Adjuvant Targeted Therapy for EGFR Positive Stage I Lung Adenocarcinomas [Phase 1, Phase 2]
Clinical trial update for ctDNA-MRD based adjuvant targeted therapy in EGFR-positive stage I lung adenocarcinoma (Phase 1/Phase 2).
-
CLINICAL_TRIALS trial_result · 2021-08-06Clinical Trial Update: Efficacy and Safety of Adjuvant Pemetrexed Plus Cisplatin for Adenocarcinoma of Lung [Phase 2]
Phase 2 trial assessing adjuvant pemetrexed plus cisplatin for lung adenocarcinoma reports efficacy and safety findings.
-
CLINICAL_TRIALS trial_result · 2021-04-28Clinical Trial Update: Targeted Stem Cells Expressing TRAIL as a Therapy for Lung Cancer [Phase 1, Phase 2]
A clinical trial update on targeted stem cells expressing TRAIL for lung cancer (adenocarcinoma of the lung) in Phase 1/2.
-
CLINICAL_TRIALS trial_result · 2020-08-20Clinical Trial Update: A Safety and Efficacy Study of Farletuzumab in Participants With Adenocarcinoma of the Lung [Phase 2]
Phase 2 trial assessing safety and efficacy of Farletuzumab in adenocarcinoma of the lung has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2020-06-23Clinical Trial Update: Chemotherapy and Radiation Therapy With or Without Metformin Hydrochloride in Treating Patients With Stage III Non-small Cell Lung Cancer [Phase 2]
A Phase 2 trial assessing whether adding metformin hydrochloride to chemotherapy and radiation improves outcomes for Stage III non-small cel…
-
CLINICAL_TRIALS trial_result · 2019-11-29Clinical Trial Update: Single Agent Chemotherapy +/- Nivolumab in Patients With Advanced Squamous or Non-squamous NSCLC With Primary Resistance to Prior PD-1 or PDL-1 Inhibitor [Phase 2]
Phase 2 trial evaluating single agent chemotherapy with or without nivolumab in advanced NSCLC patients with primary resistance to prior PD-…
-
CLINICAL_TRIALS trial_result · 2019-08-13Clinical Trial Update: Study of the Safety and Activity of Lenvatinib (E7080) in Subjects With KIF5B-RET-Positive Adenocarcinoma of the Lung [Phase 2]
Phase 2 study assessing safety and activity of lenvatinib (E7080) in KIF5B-RET–positive adenocarcinoma of the lung has completed with result…
-
CLINICAL_TRIALS trial_result · 2019-06-06Clinical Trial Update: SS1P and Pentostatin Plus Cyclophosphamide for Mesothelioma [Phase 1, Phase 2]
Phase 1/2 trial evaluating SS1P with pentostatin and cyclophosphamide for mesothelioma and related cancers has completed with results posted…
-
CLINICAL_TRIALS trial_result · 2019-02-01Clinical Trial Update: Therapeutic Strategies in Patients With Non-squamous Non-small Cell Lung Cancer With Brain Metastases [Phase 3]
A Phase 3 trial in non-squamous non-small cell lung cancer with brain metastases has been terminated; no results are provided in this update…
-
CLINICAL_TRIALS trial_result · 2016-10-17Clinical Trial Update: MK2206 and Erlotinib Hydrochloride in Treating Patients With Advanced Non-Small Cell Lung Cancer Who Have Progressed After Previous Response to Erlotinib Hydrochloride Therapy [Phase 2]
Phase 2 study evaluating MK-2206 with erlotinib in advanced non-small cell lung cancer patients who progressed after prior erlotinib; the tr…
-
CLINICAL_TRIALS trial_result · 2015-09-14Clinical Trial Update: S0536: Cetuximab, Paclitaxel, Carboplatin, and Bevacizumab in Treating Patients With Advanced Non-Small Cell Lung Cancer [Phase 2]
This Phase 2 clinical trial (S0536) evaluated the combination of cetuximab, paclitaxel, carboplatin, and bevacizumab in patients with advanc…
-
CLINICAL_TRIALS trial_result · 2015-02-16Clinical Trial Update: Therapeutic Strategy in Advanced Bronchioloalveolar Carcinoma [Phase 2]
A Phase 2 clinical trial in advanced bronchioloalveolar carcinoma (adenocarcinoma of the lung) has completed its study.
-
CLINICAL_TRIALS trial_result · 2015-01-26Clinical Trial Update: BIBW 2992 (Afatinib) vs Gemcitabine-cisplatin in 1st Line Non-small Cell Lung Cancer (NSCLC) [Phase 3]
Phase 3 trial comparing afatinib (BIBW 2992) to gemcitabine-cisplatin in first-line non-small cell lung cancer has completed with results po…
-
CLINICAL_TRIALS trial_result · 2015-01-01Clinical Trial Update: Gefitinib in Treating Patients With Stage IB, II, or IIIA Non-small Cell Lung Cancer That Was Completely Removed by Surgery [Phase 3]
Phase 3 trial evaluating gefitinib after complete surgical removal of stage IB to IIIA non-small cell lung cancer; results were posted in 20…
-
CLINICAL_TRIALS trial_result · 2014-08-21Clinical Trial Update: Bortezomib in Treating Patients With Stage IIIB or Stage IV Lung Cancer [Phase 2]
Phase 2 clinical trial of bortezomib in patients with Stage IIIB or Stage IV non-small cell lung cancer has completed, with results posted i…
-
CLINICAL_TRIALS trial_result · 2014-07-31Clinical Trial Update: Photodynamic Therapy in Treating Patients With Lung Cancer [Phase 1]
A Phase 1 trial update on photodynamic therapy for various lung cancer types, with the study status showing as completed.
-
CLINICAL_TRIALS trial_result · 2013-07-03Clinical Trial Update: Surgery With or Without Chemotherapy in Treating Patients With Stage I Non-small Cell Lung Cancer [Phase 3]
A Phase 3 trial comparing surgery with and without chemotherapy in patients with Stage I non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2013-06-05Clinical Trial Update: Combination Chemotherapy, Radiation Therapy, and Gefitinib in Treating Patients With Stage III Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 trial evaluating the combination of chemotherapy, radiation therapy, and gefitinib in patients with Stage III non-small cell lung …
-
CLINICAL_TRIALS trial_result · 2013-06-04Clinical Trial Update: Docetaxel With Either Cetuximab or Bortezomib as First-Line Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 trial evaluated first-line therapy with docetaxel plus cetuximab or docetaxel plus bortezomib in patients with Stage IIIB or Stage…
-
CLINICAL_TRIALS trial_result · 2013-02-28Clinical Trial Update: S0341: Erlotinib in Treating Patients With Advanced Primary Non-Small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating Erlotinib for advanced non-small cell lung cancer has completed.